BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

676 related articles for article (PubMed ID: 32719681)

  • 1. Probiotics and Probiotic-Derived Functional Factors-Mechanistic Insights Into Applications for Intestinal Homeostasis.
    Yan F; Polk DB
    Front Immunol; 2020; 11():1428. PubMed ID: 32719681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probiotics and gut microbiota: mechanistic insights into gut immune homeostasis through TLR pathway regulation.
    Kaur H; Ali SA
    Food Funct; 2022 Jul; 13(14):7423-7447. PubMed ID: 35766374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis.
    Tojo R; Suárez A; Clemente MG; de los Reyes-Gavilán CG; Margolles A; Gueimonde M; Ruas-Madiedo P
    World J Gastroenterol; 2014 Nov; 20(41):15163-76. PubMed ID: 25386066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Probiotics in Human Gut Microbiome-Associated Diseases.
    Kim SK; Guevarra RB; Kim YT; Kwon J; Kim H; Cho JH; Kim HB; Lee JH
    J Microbiol Biotechnol; 2019 Sep; 29(9):1335-1340. PubMed ID: 31434172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Advances and Understanding of Using Probiotic-Based Interventions to Restore Homeostasis of the Microbiome for the Prevention/Therapy of Bacterial Diseases.
    Suchodolski JS; Jergens AE
    Microbiol Spectr; 2016 Apr; 4(2):. PubMed ID: 27227298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of probiotic action: Implications for therapeutic applications in inflammatory bowel diseases.
    Vanderpool C; Yan F; Polk DB
    Inflamm Bowel Dis; 2008 Nov; 14(11):1585-96. PubMed ID: 18623173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal dysbiosis and probiotic applications in autoimmune diseases.
    de Oliveira GLV; Leite AZ; Higuchi BS; Gonzaga MI; Mariano VS
    Immunology; 2017 Sep; 152(1):1-12. PubMed ID: 28556916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in gut Microbiota mediated therapeutic targets in inflammatory bowel diseases: Emerging modalities for future pharmacological implications.
    Shamoon M; Martin NM; O'Brien CL
    Pharmacol Res; 2019 Oct; 148():104344. PubMed ID: 31400403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
    Rizzetto L; Fava F; Tuohy KM; Selmi C
    J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
    Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
    J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of probiotics in the prevention and treatment of colorectal cancer.
    Eslami M; Yousefi B; Kokhaei P; Hemati M; Nejad ZR; Arabkari V; Namdar A
    J Cell Physiol; 2019 Aug; 234(10):17127-17143. PubMed ID: 30912128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial Effects of Probiotic Consumption on the Immune System.
    Maldonado Galdeano C; Cazorla SI; Lemme Dumit JM; Vélez E; Perdigón G
    Ann Nutr Metab; 2019; 74(2):115-124. PubMed ID: 30673668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of intestinal microbiota and metabolites in inflammatory bowel disease.
    Dong LN; Wang M; Guo J; Wang JP
    Chin Med J (Engl); 2019 Jul; 132(13):1610-1614. PubMed ID: 31090547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probiotics: progress toward novel therapies for intestinal diseases.
    Yan F; Polk DB
    Curr Opin Gastroenterol; 2010 Mar; 26(2):95-101. PubMed ID: 19952741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal anti-inflammatory effect of the probiotic Saccharomyces boulardii in DSS-induced colitis in mice: Impact on microRNAs expression and gut microbiota composition.
    Rodríguez-Nogales A; Algieri F; Garrido-Mesa J; Vezza T; Utrilla MP; Chueca N; García F; Rodríguez-Cabezas ME; Gálvez J
    J Nutr Biochem; 2018 Nov; 61():129-139. PubMed ID: 30236870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential role of adherence factors in probiotic function in the gastrointestinal tract of adults and pediatrics: a narrative review of experimental and human studies.
    Gorreja F; Walker WA
    Gut Microbes; 2022; 14(1):2149214. PubMed ID: 36469568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular crosstalk of probiotic bacteria with the intestinal immune system: clinical relevance in the context of inflammatory bowel disease.
    Hörmannsperger G; Haller D
    Int J Med Microbiol; 2010 Jan; 300(1):63-73. PubMed ID: 19828372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the microbiota and probiotics in obesity.
    Fontané L; Benaiges D; Goday A; Llauradó G; Pedro-Botet J
    Clin Investig Arterioscler; 2018; 30(6):271-279. PubMed ID: 29804899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary probiotic and metabolites improve intestinal homeostasis and prevent colorectal cancer.
    Peng M; Lee SH; Rahaman SO; Biswas D
    Food Funct; 2020 Dec; 11(12):10724-10735. PubMed ID: 33231228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.